These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38739808)

  • 1. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer.
    M G A; K S A; B S U; P L R; H P S; J S; Joseph MM; T T S
    ACS Appl Mater Interfaces; 2024 May; 16(20):25710-25726. PubMed ID: 38739808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer.
    Dong Q; Wan C; Yang H; Zheng D; Xu L; Zhou Z; Xie S; Du J; Li F
    J Biomater Appl; 2020 Sep; 35(3):430-445. PubMed ID: 32515640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonic-responsive piezoelectric stimulation enhances sonodynamic therapy for HER2-positive breast cancer.
    Chen Z; Yang L; Yang Z; Wang Z; He W; Zhang W
    J Nanobiotechnology; 2024 Jun; 22(1):369. PubMed ID: 38918812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy.
    Xu P; Wang R; Yang W; Liu Y; He D; Ye Z; Chen D; Ding Y; Tu J; Shen Y
    J Nanobiotechnology; 2021 Mar; 19(1):77. PubMed ID: 33741008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
    Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
    Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
    Mondal L; Mukherjee B; Das K; Bhattacharya S; Dutta D; Chakraborty S; Pal MM; Gaonkar RH; Debnath MC
    Int J Nanomedicine; 2019; 14():8073-8094. PubMed ID: 31632019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.
    Cristofolini T; Dalmina M; Sierra JA; Silva AH; Pasa AA; Pittella F; Creczynski-Pasa TB
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110555. PubMed ID: 32228895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.
    Tan WB; Jiang S; Zhang Y
    Biomaterials; 2007 Mar; 28(8):1565-71. PubMed ID: 17161865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment.
    Shrestha B; Wang L; Zhang H; Hung CY; Tang L
    Int J Nanomedicine; 2020; 15():8109-8119. PubMed ID: 33116521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting HER3 Hyperphosphorylation in HER2-Overexpressing Breast Cancer through Multimodal Therapy with Branched Gold Nanoshells.
    Villar-Alvarez E; Golán-Cancela I; Pardo A; Velasco B; Fernández-Vega J; Cambón A; Al-Modlej A; Topete A; Barbosa S; Costoya JA; Taboada P
    Small; 2023 Dec; 19(50):e2303934. PubMed ID: 37632323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.